US hedge fund Trian Fund Management and venture capital firm General Catalyst Group Management are buying UK asset manager Janus Henderson Group for US$7.4 billion.

Fintel reports that on December 29, 2025, LifeSci Capital downgraded their outlook for Mereo BioPharma Group plc - Depositary ...

With its stock down 31% over the past three months, it is easy to disregard Janus International Group (NYSE:JBI). However, the company's fundamentals look pretty decent, and long-term financials are ...

We recently published 10 Stocks Jim Cramer Discussed. Janus Henderson Group plc (NYSE:JHG) is one of the stocks on Jim Cramer ...

Janus Henderson delivered a 6.77% return as technology holdings supported the portfolio performance. Read the full report to ...

Dubai <img decoding=async alt= border=0 width=320 data-original-height=667 data-original-width=1000 src= onerr ...

The agreement by a Trian-backed group to acquire Janus Henderson in a $7.4 billion transaction marks one of the most ...

Janus brought several innovations to the asset management market, including the asset-backed securities ETF (JABS) and the ...

Global asset manager Janus Henderson is set to leave the public markets in a $7.4 billion all-cash acquisition led by Trian ...

Trian Fund Management, owned by activist hedge fund manager Nelson Peltz, and venture firm General Catalyst are taking over ...

Janus Henderson is being acquired for US$7.4 billion and will be delisted from the New York Stock Exchange (NYSE) following the completion of the transaction.

Global asset manager Janus Henderson has been acquired by Trian Fund Management and General Catalyst in a US$7.4 billion deal ...